FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer

Published:2024-03-16 Issue:12 Volume:9 Page:14323-14335
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Hoover Elise C.¹^ORCID,Ruggiero Olivia M.¹,Swingler Rachel N.¹,Day Emily S.¹²³^ORCID

Affiliation:

1. Department of Biomedical Engineering, University of Delaware, Newark, Delaware 19713, United States

2. Department of Materials Science and Engineering, University of Delaware, Newark, Delaware 19716, United States

3. Helen F. Graham Cancer Center and Research Institute, Newark, Delaware 19713, United States

Funder

National Cancer Institute

University of Delaware

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c10275

Reference58 articles.

1. CDCBreastCancer. Breast Cancer Statistics. Centers for Disease Control and Prevention. 2023 https://www.cdc.gov/cancer/breast/statistics/index.htm. (accessed September 14, 2023).

2. American Cancer Society. Breast Cancer Facts & Figures. 2017, pp 2017–2018.

3. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype

4. Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer

5. Triple-negative breast cancer molecular subtyping and treatment progress

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP